6.
Arora S, Stouffer G, Kucharska-Newton A, Qamar A, Vaduganathan M, Pandey A
. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Circulation. 2018; 139(8):1047-1056.
PMC: 6380926.
DOI: 10.1161/CIRCULATIONAHA.118.037137.
View
7.
Yeh R, Sidney S, Chandra M, Sorel M, Selby J, Go A
. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362(23):2155-65.
DOI: 10.1056/NEJMoa0908610.
View
8.
Li F, Bai T, Ren Y, Xue Q, Hu J, Cao J
. A systematic review and meta-analysis of the association between sarcopenia and myocardial infarction. BMC Geriatr. 2023; 23(1):11.
PMC: 9825023.
DOI: 10.1186/s12877-022-03712-1.
View
9.
Chyau C, Wang H, Zhang W, Chen C, Huang S, Chang C
. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. Int J Mol Sci. 2020; 21(1).
PMC: 6981486.
DOI: 10.3390/ijms21010360.
View
10.
Chaudhry S, Khan R, Chen J, Dharmarajan K, Dodson J, Masoudi F
. National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010. J Am Heart Assoc. 2014; 3(5):e001197.
PMC: 4323804.
DOI: 10.1161/JAHA.114.001197.
View
11.
Alkhouri N, Tamimi T, Yerian L, Lopez R, Zein N, Feldstein A
. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig Dis Sci. 2009; 55(9):2644-50.
DOI: 10.1007/s10620-009-1075-y.
View
12.
Yarzebski J, Bujor C, Lessard D, Gore J, Goldberg R
. Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: a population-based perspective. Am Heart J. 2004; 147(4):690-7.
DOI: 10.1016/j.ahj.2003.10.023.
View
13.
Labenz C, Huber Y, Michel M, Nagel M, Galle P, Kostev K
. Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany. Dig Dis Sci. 2019; 65(7):2112-2119.
DOI: 10.1007/s10620-019-05986-9.
View
14.
Deprince A, Haas J, Staels B
. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020; 42:101092.
PMC: 7600388.
DOI: 10.1016/j.molmet.2020.101092.
View
15.
Adiels M, Olofsson S, Taskinen M, Boren J
. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008; 28(7):1225-36.
DOI: 10.1161/ATVBAHA.107.160192.
View
16.
Kasper P, Martin A, Lang S, Kutting F, Goeser T, Demir M
. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2020; 110(7):921-937.
PMC: 8238775.
DOI: 10.1007/s00392-020-01709-7.
View
17.
Mahfood Haddad T, Hamdeh S, Kanmanthareddy A, Alla V
. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. Diabetes Metab Syndr. 2016; 11 Suppl 1:S209-S216.
DOI: 10.1016/j.dsx.2016.12.033.
View
18.
Satapathy S, Sanyal A
. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2015; 35(3):221-35.
DOI: 10.1055/s-0035-1562943.
View
19.
Olubamwo O, Virtanen J, Voutilainen A, Kauhanen J, Pihlajamaki J, Tuomainen T
. Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction. Eur J Gastroenterol Hepatol. 2018; 30(9):1047-1054.
DOI: 10.1097/MEG.0000000000001183.
View
20.
Cai J, Zhang S, Huang W
. Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis. Int J Clin Exp Med. 2015; 8(5):7673-8.
PMC: 4509261.
View